These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15916097)

  • 1. Immunizing children to protect against the increasing risk of hepatitis A in adolescents and young adults in South Korea.
    Sohn YM; Lee JS; Park JH; Poerschke G; Eves K; Gress J; Kuter B
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):954-8. PubMed ID: 15916097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
    Roberton D; Marshall H; Nolan TM; Sokal E; Díez-Domingo J; Flodmark CE; Rombo L; Lewald G; Flor Jde L; Casanovas JM; Verdaguer J; Marés J; Esso DV; Dieussaert I; Stoffel M
    Vaccine; 2005 Oct; 23(43):5099-105. PubMed ID: 16055231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy.
    Lee D; Cho YA; Park Y; Hwang JH; Kim JW; Kim NY; Lee DH; Lee W; Jeong SH
    Intervirology; 2008; 51(2):70-4. PubMed ID: 18434743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing epidemiology of hepatitis A in children and the consideration of active immunization in Korea.
    Sohn YM; Rho HO; Park MS; Park JH; Choi BY; Ki M; Jang WI
    Yonsei Med J; 2000 Feb; 41(1):34-9. PubMed ID: 10731917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field performance of VAQTA (inactivated, purified hepatitis a vaccine) in Chinese children in Jiangsu.
    Wang H; Chen X; Chen Z; Lu W; Poerschke G; Eves K; Gress J; Kuter B
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):949-53. PubMed ID: 15916096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program.
    Chodick G; Heymann AD; Ashkenazi S; Kokia E; Shalev V
    J Viral Hepat; 2008 Oct; 15 Suppl 2():62-5. PubMed ID: 18837837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind study in healthy adults to assess the boosting effect of Vaqta or Havrix after a single dose of Havrix.
    Connor BA; Phair J; Sack D; McEniry D; Hornick R; Banerjee D; Jensen E; Kuter B
    Clin Infect Dis; 2001 Feb; 32(3):396-401. PubMed ID: 11170947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A vaccine recommendations.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):189-99. PubMed ID: 17606579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
    Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
    Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM
    J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program.
    Belmaker I; Dukhan L; Yosef Y; Leventhal A; Dagan R
    Pediatr Infect Dis J; 2007 Jan; 26(1):36-40. PubMed ID: 17195703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
    Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
    D'Acremont V; Herzog C; Genton B
    J Travel Med; 2006; 13(2):78-83. PubMed ID: 16553593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of liver diseases in Korea: hepatitis A.
    Kwon SY
    Korean J Hepatol; 2009 Dec; 15 Suppl 6():S7-12. PubMed ID: 20037282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis A in Poland in 2003].
    Magdzik W
    Przegl Epidemiol; 2005; 59(2):289-95. PubMed ID: 16190532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs.
    Pancharoen C; Mekmullica J; Thisyakorn U; Kasempimolporn S; Wilde H; Herzog C
    Clin Infect Dis; 2005 Nov; 41(10):1537-40. PubMed ID: 16231271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A outbreaks: the effect of a mass vaccination programme.
    Torner N; Broner S; Martinez A; Godoy P; Batalla J; Dominguez A;
    J Viral Hepat; 2011 Apr; 18(4):e1-4. PubMed ID: 21129127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP-IPV-PRP approximately T-HBs) combination vaccine.
    Stojanov S; Liese JG; Belohradsky BH; Vandermeulen C; Hoppenbrouwers K; Van der Wielen M; Van Damme P; Georges B; Dupuy M; Scemama M; Watson M; Fiquet A; Stek JE; Golm GT; Schödel FP; Kuter BJ;
    Vaccine; 2007 Oct; 25(43):7549-58. PubMed ID: 17905486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.